Unity Bio Ownership 2024 | Who Owns Unity Bio Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

1.11%

Insider Ownership

1.33%

Retail Ownership

97.55%

Institutional Holders

2.00

Unity Bio Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALYESKA INVESTMENT GROUP, L.P.13.54%0.02%1,286,0001,286,000100.00%2,096,180,000Mar 31, 2023
ARCH VENTURE MANAGEMENT, LLC10.58%0.79%1,004,817--1,637,852,000Mar 31, 2023
VANGUARD GROUP INC5.52%-523,92480,10018.05%853,996,000Mar 31, 2023
FMR LLC3.03%-287,987-475,133-62.26%469,419,000Mar 31, 2023
UBS OCONNOR LLC2.24%0.02%213,040--347,255,000,000Mar 31, 2023
MAYO CLINIC1.66%0.21%157,198157,198100.00%256,233,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC1.30%-122,98331,88235.00%200,462,000Mar 31, 2023
BLACKROCK INC.1.13%-107,49637,07852.65%175,218,000Mar 31, 2023
EXODUSPOINT CAPITAL MANAGEMENT, LP0.99%0.00%93,59717,69723.32%153,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.82%0.00%77,471-13,700-15.03%126,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP0.74%0.00%70,000--114,100,000Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP0.72%-67,89937,473123.16%110,675,000Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.53%0.00%50,000-10,705-17.63%81,500,000Mar 31, 2023
SIMPLEX TRADING, LLC0.52%0.00%49,700-516,600-91.22%81,000Mar 31, 2023
FOUNDERS FUND V MANAGEMENT, LLC0.52%6.17%49,172-442,579-90.00%80,150,000Mar 31, 2023
MORGAN STANLEY0.50%-47,4512,3975.32%77,345,000Mar 31, 2023
CERCANO MANAGEMENT LLC0.43%0.00%41,238--67,218,000Mar 31, 2023
ALYESKA INVESTMENT GROUP, L.P.0.41%0.00%38,695-658,753-94.45%63,073,000Mar 31, 2023
STATE STREET CORP0.40%-38,16413,30053.49%62,207,000Mar 31, 2023
WOLVERINE TRADING, LLC0.30%0.00%28,30028,300100.00%48,000Mar 31, 2023

Unity Bio's largest institutional shareholder is ALYESKA INVESTMENT GROUP, L.P., holding 13.54% of the company's total share outstanding, currently valued at $2.10B. The top 10 institutional shareholders own together 40.81% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FOUNDERS FUND V MANAGEMENT, LLC0.52%6.17%49,172-442,579-90.00%80,150,000Mar 31, 2023
ARCH VENTURE MANAGEMENT, LLC10.58%0.79%1,004,817--1,637,852,000Mar 31, 2023
MAYO CLINIC1.66%0.21%157,198157,198100.00%256,233,000Mar 31, 2023
ALYESKA INVESTMENT GROUP, L.P.13.54%0.02%1,286,0001,286,000100.00%2,096,180,000Mar 31, 2023
UBS OCONNOR LLC2.24%0.02%213,040--347,255,000,000Mar 31, 2023
ARETE WEALTH ADVISORS, LLC0.11%0.01%10,392--142,298,000,000Mar 31, 2023
CERCANO MANAGEMENT LLC0.43%0.00%41,238--67,218,000Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.53%0.00%50,000-10,705-17.63%81,500,000Mar 31, 2023
JOHNSON MIDWEST FINANCIAL, LLC0.01%0.00%661--1,077,000Mar 31, 2023
EXODUSPOINT CAPITAL MANAGEMENT, LP0.99%0.00%93,59717,69723.32%153,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP0.74%0.00%70,000--114,100,000Mar 31, 2023
ALYESKA INVESTMENT GROUP, L.P.0.41%0.00%38,695-658,753-94.45%63,073,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.82%0.00%77,471-13,700-15.03%126,000Mar 31, 2023
TWO SIGMA INVESTMENTS, LP0.21%0.00%19,60019,600100.00%31,948,000Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC0.26%0.00%24,5128,49953.08%39,000Mar 31, 2023
CARMICHAEL HILL & ASSOCIATES, INC.0.00%0.00%100--163,000Mar 31, 2023
WOLVERINE TRADING, LLC0.30%0.00%28,30028,300100.00%48,000Mar 31, 2023
SIMPLEX TRADING, LLC0.52%0.00%49,700-516,600-91.22%81,000Mar 31, 2023
CIBC ASSET MANAGEMENT INC0.11%0.00%10,63410,634100.00%17,333,000Mar 31, 2023
ALLSQUARE WEALTH MANAGEMENT LLC0.00%0.00%55--90,000Mar 31, 2023

The largest Unity Bio shareholder by % of total assets is FOUNDERS FUND V MANAGEMENT, LLC. The company owns 49.17K shares of Unity Bio (UBX), representing 6.17% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALYESKA INVESTMENT GROUP, L.P.13.54%0.02%1,286,0001,286,000100.00%2,096,180,000Mar 31, 2023
MAYO CLINIC1.66%0.21%157,198157,198100.00%256,233,000Mar 31, 2023
VANGUARD GROUP INC5.52%-523,92480,10018.05%853,996,000Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP0.72%-67,89937,473123.16%110,675,000Mar 31, 2023
BLACKROCK INC.1.13%-107,49637,07852.65%175,218,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC1.30%-122,98331,88235.00%200,462,000Mar 31, 2023
WOLVERINE TRADING, LLC0.30%0.00%28,30028,300100.00%48,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.30%-28,25528,255100.00%46,056,000Mar 31, 2023
TWO SIGMA INVESTMENTS, LP0.21%0.00%19,60019,600100.00%31,948,000Mar 31, 2023
EXODUSPOINT CAPITAL MANAGEMENT, LP0.99%0.00%93,59717,69723.32%153,000Mar 31, 2023
STATE STREET CORP0.40%-38,16413,30053.49%62,207,000Mar 31, 2023
CITADEL ADVISORS LLC0.23%-21,95012,560133.76%35,779,000Mar 31, 2023
CIBC ASSET MANAGEMENT INC0.11%0.00%10,63410,634100.00%17,333,000Mar 31, 2023
CITADEL ADVISORS LLC0.13%-12,4008,990263.64%20,212,000Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC0.26%0.00%24,5128,49953.08%39,000Mar 31, 2023
SIMPLEX TRADING, LLC0.07%-6,3005,8001160.00%10,000Mar 31, 2023
SIMPLEX TRADING, LLC0.05%-4,5174,517100.00%7,000Mar 31, 2023
MORGAN STANLEY0.50%-47,4512,3975.32%77,345,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.00%-290290100.00%473,000Mar 31, 2023
WEALTHPLAN PARTNERS, LLC0.00%-1010100.00%16,000Mar 31, 2023

As of Mar 31 2023, Unity Bio's largest institutional buyer is ALYESKA INVESTMENT GROUP, L.P.. The company purchased 1.29M stocks of UBX, valued at $2.10B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALYESKA INVESTMENT GROUP, L.P.0.41%0.00%38,695-658,753-94.45%63,073,000Mar 31, 2023
SIMPLEX TRADING, LLC0.52%0.00%49,700-516,600-91.22%81,000Mar 31, 2023
FMR LLC3.03%-287,987-475,133-62.26%469,419,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.10%0.00%9,600-461,800-97.96%15,648,000Mar 31, 2023
FOUNDERS FUND V MANAGEMENT, LLC0.52%6.17%49,172-442,579-90.00%80,150,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP----380,800-100.00%-Mar 31, 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.----250,000-100.00%-Mar 31, 2023
683 CAPITAL MANAGEMENT, LLC----240,000-100.00%-Mar 31, 2023
MAYO CLINIC----157,198-100.00%-Mar 31, 2023
CANTOR FITZGERALD, L. P.----144,500-100.00%-Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC0.08%-7,667-97,021-92.68%11,000Mar 31, 2023
CVI HOLDINGS, LLC----74,100-100.00%-Mar 31, 2023
PARKMAN HEALTHCARE PARTNERS LLC----42,749-100.00%-Mar 31, 2023
CITADEL ADVISORS LLC0.03%-2,593-31,527-92.40%4,227,000Mar 31, 2023
VIRTU FINANCIAL LLC----20,155-100.00%-Mar 31, 2023
BAILARD, INC.----17,700-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----16,546-100.00%-Mar 31, 2023
SCHONFELD STRATEGIC ADVISORS LLC----14,000-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.82%0.00%77,471-13,700-15.03%126,000Mar 31, 2023
JANE STREET GROUP, LLC----13,460-100.00%-Mar 31, 2023

As of Mar 31 2023, Unity Bio's biggest institutional seller is ALYESKA INVESTMENT GROUP, L.P.. The company sold -0.66M shares of UBX, valued at $63.07M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALYESKA INVESTMENT GROUP, L.P.13.54%0.02%1,286,0001,286,000100.00%2,096,180,000Mar 31, 2023
MAYO CLINIC1.66%0.21%157,198157,198100.00%256,233,000Mar 31, 2023
WOLVERINE TRADING, LLC0.30%0.00%28,30028,300100.00%48,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.30%-28,25528,255100.00%46,056,000Mar 31, 2023
TWO SIGMA INVESTMENTS, LP0.21%0.00%19,60019,600100.00%31,948,000Mar 31, 2023
CIBC ASSET MANAGEMENT INC0.11%0.00%10,63410,634100.00%17,333,000Mar 31, 2023
SIMPLEX TRADING, LLC0.05%-4,5174,517100.00%7,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.00%-290290100.00%473,000Mar 31, 2023
WEALTHPLAN PARTNERS, LLC0.00%-1010100.00%16,000Mar 31, 2023
WESTSIDE INVESTMENT MANAGEMENT, INC.0.00%-1010100.00%16,000Mar 31, 2023

Unity Bio's largest new institutional shareholder by number of shares is ALYESKA INVESTMENT GROUP, L.P., purchased 1.29M shares, valued at $2.10B, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP----380,800-100.00%-Mar 31, 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.----250,000-100.00%-Mar 31, 2023
683 CAPITAL MANAGEMENT, LLC----240,000-100.00%-Mar 31, 2023
MAYO CLINIC----157,198-100.00%-Mar 31, 2023
CANTOR FITZGERALD, L. P.----144,500-100.00%-Mar 31, 2023
CVI HOLDINGS, LLC----74,100-100.00%-Mar 31, 2023
PARKMAN HEALTHCARE PARTNERS LLC----42,749-100.00%-Mar 31, 2023
VIRTU FINANCIAL LLC----20,155-100.00%-Mar 31, 2023
BAILARD, INC.----17,700-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----16,546-100.00%-Mar 31, 2023
SCHONFELD STRATEGIC ADVISORS LLC----14,000-100.00%-Mar 31, 2023
JANE STREET GROUP, LLC----13,460-100.00%-Mar 31, 2023
GROUP ONE TRADING, L.P.----12,700-100.00%-Mar 31, 2023
BELVEDERE TRADING LLC----11,600-100.00%-Mar 31, 2023
PRIME CAPITAL INVESTMENT ADVISORS, LLC----11,420-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----10,349-100.00%-Mar 31, 2023
UBS GROUP AG----8,004-100.00%-Mar 31, 2023
ROYAL BANK OF CANADA----338-100.00%-Mar 31, 2023
FEDERATED HERMES, INC.----205-100.00%-Mar 31, 2023
ROSENBERG MATTHEW HAMILTON----200-100.00%-Mar 31, 2023
MONEY CONCEPTS CAPITAL CORP----60-100.00%-Mar 31, 2023
CORRADO ADVISORS, LLC----58-100.00%-Mar 31, 2023

Unity Bio's largest sold out institutional shareholder by shares sold is SUSQUEHANNA INTERNATIONAL GROUP, LLP, sold -0.38M shares, valued at -, as of undefined.

Unity Bio Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY MT VERNON STREET TRUST0.14%4,106,954--Feb 29, 2024
BRIDGEWAY FUNDS INC0.04%107,050--Dec 29, 2023
ETFis Series Trust I0.03%44,703--Jan 31, 2024
SMALLCAP WORLD FUND INC0.03%1,835,000--Dec 31, 2023
BRIDGEWAY FUNDS INC0.02%50,000--Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS0.02%9,250--Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.02%433,473--Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%6,145--Dec 31, 2023
VANGUARD INDEX FUNDS0.01%4,331,194--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.01%55,684--Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.01%1,868--Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.01%21,887--Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.00%223,800--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%393,058--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%747,137194,78535.26%Dec 31, 2023
Calvert Variable Products, Inc.0.00%2,907--Dec 31, 2023
SCHWAB CAPITAL TRUST0.00%45,951--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%31,699--Dec 31, 2023
Principal Exchange-Traded Funds0.00%10,511--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%132,336--Feb 29, 2024
GPS Funds I0.00%2,876--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%72,900--Jan 31, 2024
SunAmerica Specialty Series0.00%287--Apr 30, 2021
Voya VARIABLE PORTFOLIOS INC0.00%16,486--Dec 31, 2023
OLD WESTBURY FUNDS INC0.00%67,344--Jan 31, 2024
OHIO NATIONAL FUND INC0.00%7,381--Dec 31, 2023
Federated Hermes Global Allocation Fund0.00%1,537--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%415--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%17,700--Jan 31, 2024
PACE SELECT ADVISORS TRUST0.00%42,628--Jan 31, 2024
FIDELITY SALEM STREET TRUST0.00%253,350--Feb 29, 2024
Legg Mason Global Asset Management Trust0.00%100,000--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,137--Dec 31, 2023
ProFunds0.00%769--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%6,490--Dec 31, 2023
RBB FUND, INC.0.00%6,262--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%5,174--Dec 31, 2023
HC CAPITAL TRUST0.00%1,802--Dec 31, 2023
VALIC Co I0.00%16,819--Feb 29, 2024
PGIM ETF TRUST0.00%3,811--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%114,896--Feb 29, 2024
RUSSELL INVESTMENT CO0.00%13,962--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%6,035--Dec 31, 2023
Meeder Funds0.00%195--Mar 31, 2024
PROSHARES TRUST0.00%10,044--Feb 29, 2024
RUSSELL INVESTMENT FUNDS0.00%2,544--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%43,162--Dec 31, 2023
PENN SERIES FUNDS INC0.00%900--Dec 29, 2023
Dimensional ETF Trust0.00%13,752-25,967-65.38%Jan 31, 2024
T. Rowe Price Index Trust, Inc.0.00%412--Feb 29, 2024
NORTHERN FUNDS0.00%18,827--Dec 29, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%19,401--Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,781--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%29,600--Dec 31, 2023
VANGUARD WELLINGTON FUND0.00%5,058--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%4,000--Jan 31, 2024
Legg Mason Global Asset Management Trust0.00%10,000--Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%30,141--Dec 31, 2023
Brighthouse Funds Trust II0.00%14,678--Dec 31, 2023
iSHARES TRUST0.00%108,210--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%6,671--Jan 31, 2024
EQ ADVISORS TRUST0.00%7,493--Dec 31, 2023
MASTER INVESTMENT PORTFOLIO0.00%517--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%366--Feb 29, 2024
PACIFIC SELECT FUND0.00%14,999--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%4,462--Dec 31, 2023
WisdomTree Trust0.00%4,406--Feb 29, 2024
EQ ADVISORS TRUST0.00%2,538--Dec 31, 2023
Bridge Builder Trust0.00%13,641--Dec 31, 2023
Dimensional ETF Trust0.00%860--Jan 31, 2024
iSHARES TRUST0.00%29,369--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%567--Jan 31, 2024
Advisors' Inner Circle Fund III0.00%16--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%4,476--Dec 31, 2023
PRINCIPAL FUNDS, INC.0.00%6,507--Feb 29, 2024
BLACKROCK FUNDS0.00%3,431--Feb 29, 2024
John Hancock Funds II0.00%6,073--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%783--Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%5,800--Feb 29, 2024

Unity Bio's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 4.11M shares, compromising 0.14% of its total assets.

Unity Bio Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 222-96.43%
30 Sep, 2256-
30 Jun, 2256-9.68%
31 Mar, 2262-4.62%
31 Dec, 2165-14.47%
30 Sep, 2176-17.39%
30 Jun, 21926.98%
31 Mar, 21864.88%
31 Dec, 20821.23%
30 Sep, 2081-
30 Jun, 208114.08%
31 Mar, 2071-8.97%
31 Dec, 197827.87%
30 Sep, 196110.91%
30 Jun, 19551.85%
31 Mar, 19541.89%
31 Dec, 185329.27%
30 Sep, 1841-
30 Jun, 1841-

As of 31 Dec 22, 2 institutions are holding Unity Bio's shares, representing a decrease of -96.43% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 22157,398-99.68%
30 Sep, 2248,816,031421.98%
30 Jun, 229,352,028-24.68%
31 Mar, 2212,416,727-12.89%
31 Dec, 2114,254,3375.37%
30 Sep, 2113,527,278-24.87%
30 Jun, 2118,004,612-11.07%
31 Mar, 2120,245,690-2.69%
31 Dec, 2020,804,9085.79%
30 Sep, 2019,666,218-21.05%
30 Jun, 2024,909,78313.85%
31 Mar, 2021,879,0390.37%
31 Dec, 1921,798,11933.54%
30 Sep, 1916,323,559-1.38%
30 Jun, 1916,552,4380.98%
31 Mar, 1916,392,1613.57%
31 Dec, 1815,827,87024.16%
30 Sep, 1812,747,608-0.41%
30 Jun, 1812,800,023-

Unity Bio (UBX) has 157.40K shares outstanding as of 31 Dec 22, down -99.68% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 221.11%0.00%
30 Sep, 22484.67%2.66%
30 Jun, 22135.05%0.40%
31 Mar, 22183.87%0.31%
31 Dec, 21242.62%0.41%
30 Sep, 21244.01%0.23%
30 Jun, 21328.19%0.23%
31 Mar, 21373.75%0.24%
31 Dec, 20390.90%0.28%
30 Sep, 20374.72%0.15%
30 Jun, 20501.62%0.24%
31 Mar, 20460.18%0.20%
31 Dec, 19474.12%0.33%
30 Sep, 19379.92%0.25%
30 Jun, 19389.99%0.26%
31 Mar, 19388.53%0.26%
31 Dec, 18383.97%0.40%
30 Sep, 18310.48%0.13%
30 Jun, 18486.72%-

As of 31 Dec 22, Unity Bio is held by 1.11% institutional shareholders, representing a 0.00% growth compared to 30 Sep 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 221-97.14%
30 Sep, 223545.83%
30 Jun, 22244.35%
31 Mar, 2223-32.35%
31 Dec, 213447.83%
30 Sep, 2123-46.51%
30 Jun, 214322.86%
31 Mar, 2135-28.57%
31 Dec, 204919.51%
30 Sep, 2041-19.61%
30 Jun, 205164.52%
31 Mar, 2031-43.64%
31 Dec, 195583.33%
30 Sep, 1930-16.67%
30 Jun, 19362.86%
31 Mar, 1935-12.50%
31 Dec, 184048.15%
30 Sep, 1827-34.15%
30 Jun, 1841-

1 institutional shareholders have increased their position in UBX stock as of 31 Dec 22 compared to 35 in the previous quarter (a -97.14% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 221-85.71%
30 Sep, 227-53.33%
30 Jun, 2215-16.67%
31 Mar, 221838.46%
31 Dec, 2113-51.85%
30 Sep, 212717.39%
30 Jun, 2123-11.54%
31 Mar, 2126100.00%
31 Dec, 2013-45.83%
30 Sep, 202484.62%
30 Jun, 2013-45.83%
31 Mar, 2024118.18%
31 Dec, 1911-35.29%
30 Sep, 1917112.50%
30 Jun, 198-20.00%
31 Mar, 191066.67%
31 Dec, 18620.00%
30 Sep, 185-
30 Jun, 18--

1 institutional shareholders have reduced their position in UBX stock as of 31 Dec 22 compared to 7 in the previous quarter (a -85.71% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 222-96.43%157,398-99.68%1.11%0.00%1-97.14%1-85.71%
30 Sep, 2256-48,816,031421.98%484.67%2.66%3545.83%7-53.33%
30 Jun, 2256-9.68%9,352,028-24.68%135.05%0.40%244.35%15-16.67%
31 Mar, 2262-4.62%12,416,727-12.89%183.87%0.31%23-32.35%1838.46%
31 Dec, 2165-14.47%14,254,3375.37%242.62%0.41%3447.83%13-51.85%
30 Sep, 2176-17.39%13,527,278-24.87%244.01%0.23%23-46.51%2717.39%
30 Jun, 21926.98%18,004,612-11.07%328.19%0.23%4322.86%23-11.54%
31 Mar, 21864.88%20,245,690-2.69%373.75%0.24%35-28.57%26100.00%
31 Dec, 20821.23%20,804,9085.79%390.90%0.28%4919.51%13-45.83%
30 Sep, 2081-19,666,218-21.05%374.72%0.15%41-19.61%2484.62%
30 Jun, 208114.08%24,909,78313.85%501.62%0.24%5164.52%13-45.83%
31 Mar, 2071-8.97%21,879,0390.37%460.18%0.20%31-43.64%24118.18%
31 Dec, 197827.87%21,798,11933.54%474.12%0.33%5583.33%11-35.29%
30 Sep, 196110.91%16,323,559-1.38%379.92%0.25%30-16.67%17112.50%
30 Jun, 19551.85%16,552,4380.98%389.99%0.26%362.86%8-20.00%
31 Mar, 19541.89%16,392,1613.57%388.53%0.26%35-12.50%1066.67%
31 Dec, 185329.27%15,827,87024.16%383.97%0.40%4048.15%620.00%
30 Sep, 1841-12,747,608-0.41%310.48%0.13%27-34.15%5-
30 Jun, 1841-12,800,023-486.72%-41---

Unity Bio Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell603$1.55$934.6578,143
Feb 05, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell680$1.71$1.16K78,746
Jan 31, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,183$1.71$2.02K79,426
Nov 03, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell589$1.83$1.08K80,609
Oct 31, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,024$1.90$1.95K81,198
Sep 15, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,246$2.47$3.08K82,222
Aug 03, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell581$2.94$1.71K83,468
Aug 01, 2023Ghosh Anirvanofficer Chief Executive OfficerS-SaleSell1,020$2.86$2.92K84,049
Jun 27, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,177$3.20$3.77K85,069
Jun 15, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,212$3.39$4.11K86,246

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell603$1.55$934.6578,143
Feb 05, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell680$1.71$1.16K78,746
Jan 31, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,183$1.71$2.02K79,426
Nov 03, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell589$1.83$1.08K80,609
Oct 31, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,024$1.90$1.95K81,198
Sep 15, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,246$2.47$3.08K82,222
Aug 03, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell581$2.94$1.71K83,468
Aug 01, 2023Ghosh Anirvanofficer Chief Executive OfficerS-SaleSell1,020$2.86$2.92K84,049
Jun 27, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,177$3.20$3.77K85,069
Jun 15, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,212$3.39$4.11K86,246

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 03, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell603$1.55$934.6578,143
Mar 27, 2024Nguyen Alexander Hieuofficer Chief Legal OfficerA-AwardBuy30,000$1.62$48.60K30,000
Mar 27, 2024Nguyen Alexander Hieuofficer Chief Legal OfficerA-AwardBuy20,000--25,104
Feb 05, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell680$1.71$1.16K78,746
Jan 31, 2024Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,183$1.71$2.02K79,426
Nov 03, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell589$1.83$1.08K80,609
Oct 31, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,024$1.90$1.95K81,198
Sep 15, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,246$2.47$3.08K82,222
Aug 03, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell581$2.94$1.71K83,468
Aug 01, 2023Ghosh Anirvanofficer Chief Executive OfficerS-SaleSell1,020$2.86$2.92K84,049
Jun 27, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,177$3.20$3.77K85,069
Jun 26, 2023Samuels Camille Ddirector-A-AwardBuy6,000$3.25$19.50K6,000
Jun 26, 2023BERNS PAUL Ldirector-A-AwardBuy6,000$3.25$19.50K6,000
Jun 26, 2023O'Neill Gilmore Neildirector-A-AwardBuy6,000$3.25$19.50K6,000
Jun 26, 2023Roberts Margo Rdirector-A-AwardBuy6,000$3.25$19.50K6,000
Jun 26, 2023Samar Michael P.director-A-AwardBuy6,000$3.25$19.50K6,000
Jun 26, 2023Leonard Keith Rdirector-A-AwardBuy6,000$3.25$19.50K6,000
Jun 26, 2023David Nathaniel Edirector-A-AwardBuy6,000$3.25$19.50K6,000
Jun 15, 2023Ghosh Anirvandirector, officer Chief Executive OfficerS-SaleSell1,212$3.39$4.11K86,246
May 12, 2023Sullivan Lynne Marieofficer See RemarksA-AwardBuy40,000$2.77$110.80K40,000

The last insider sell of Unity Bio's stock was made by Ghosh Anirvan on May 03 2024, selling 603 shares at $1.55 per share (valued at $934.65).

Unity Bio Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-1-
Q1 202422100.00%
Q4 2023-2-
Q3 2023-3-
Q2 20231913146.15%
Q1 2023-7-
Q4 202243133.33%
Q3 2022-3-
Q2 2022166266.67%
Q1 202284200.00%
Q4 2021-1-
Q2 20211611600.00%
Q1 202142200.00%
Q4 20201425.00%
Q3 202061600.00%
Q2 202096150.00%
Q1 20201511500.00%
Q4 2019---
Q3 20194--
Q2 20192012000.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Unity Bio's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-1-
Q1 2024-2-
Q4 2023-2-
Q3 2023-3-
Q2 2023-4-
Q1 2023-7-
Q4 2022-3-
Q3 2022-3-
Q2 2022-3-
Q1 2022---
Q4 2021---
Q2 2021---
Q1 2021---
Q4 2020-1-
Q3 2020---
Q2 20201--
Q1 2020---
Q4 2019---
Q3 2019---
Q2 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Unity Bio's stocks.

Unity Bio Peer Ownership


TickerCompany
VERVVerve Therapeutics, Inc.
ABOSAcumen Pharmaceuticals, Inc.
AVIRAtea Pharmaceuticals, Inc.
ENSCEnsysce Biosciences, Inc.
NUVBNuvation Bio Inc.
PRMEPrime Medicine, Inc.
NXTCNextCure, Inc.
PBLAPanbela Therapeutics, Inc.
NTLAIntellia Therapeutics, Inc.
WINTWindtree Therapeutics, Inc.
HRTXHeron Therapeutics, Inc.
EDITEditas Medicine, Inc.
CNTBConnect Biopharma Holdings Limited
RXRXRecursion Pharmaceuticals, Inc.
HOOKHOOKIPA Pharma Inc.
DRMADermata Therapeutics, Inc.
OVIDOvid Therapeutics Inc.
BEAMBeam Therapeutics Inc.
NLTXNeurogene Inc.
BXRXBaudax Bio, Inc.
EXAIExscientia plc
FIXXQ32 Bio Inc.
RNAAvidity Biosciences, Inc.

UBX Ownership FAQ


Unity Bio is owned by institutional shareholders (1.11%), insiders (1.33%), and public (97.55%). The largest institutional shareholder of Unity Bio is ALYESKA INVESTMENT GROUP, L.P. (13.54% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.14% of total shares).

Unity Bio's major institutional shareholders are ALYESKA INVESTMENT GROUP, L.P., ARCH VENTURE MANAGEMENT, LLC, VANGUARD GROUP INC, FMR LLC, and UBS OCONNOR LLC. The top five shareholders own together 34.92% of the company's share outstanding.

As of Dec 2022, there are 2 institutional shareholders of Unity Bio.

ALYESKA INVESTMENT GROUP, L.P owns 1.29M shares of Unity Bio, representing 13.54% of the company's total shares outstanding, valued at $2.1B (as of Mar 2023).

As of Mar 2023, ARCH VENTURE MANAGEMENT, LLC holds 1M shares of Unity Bio (UBX), compromising 10.58% of the company, valued at $1.64B.

VANGUARD GROUP INC is the third largest holder of Unity Bio. The company owns 523.92K of the company's shares outstanding (worth $854M).